Awakn Life Sciences has announced the successful completion of phase one of its new chemical entity (NCE) development program, strengthening Awakn’s pipeline for the treatment of a broad range of both substance and behavioural addictions.
Category Press Release
Published in Awakn Life Sciences
Companies Featured
Awakn Life SciencesAWAKN Life Sciences aims to bring psychedelics therapy to the UK. Under this company fall three arms; psychedelic research, clinic platform, and practitioner training.